Dr Mary Louise Ulrickson, MD | |
824 Westwood Dr S, Golden Valley, MN 55416-3355 | |
(763) 377-6341 | |
Not Available |
Full Name | Dr Mary Louise Ulrickson |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 824 Westwood Dr S, Golden Valley, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538505862 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 28017 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mary Louise Ulrickson, MD 824 Westwood Dr S, Golden Valley, MN 55416-3355 Ph: (763) 377-6341 | Dr Mary Louise Ulrickson, MD 824 Westwood Dr S, Golden Valley, MN 55416-3355 Ph: (763) 377-6341 |
News Archive
diaDexus, a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced that the U.S. Food and Drug Administration has cleared for marketing the automated version of its proprietary PLACĀ® Test.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 50 mg, 100 mg, 150mg, 200 mg, and 250mg strength armodafinil tablets prior to the expiration of patents owned by Cephalon France.
Focusing on certain PTSD symptoms may be key to treating anger among Iraq/Afghanistan Veterans, according to a study by University of North Carolina at Chapel Hill and Veterans Affairs researchers.
Research brings together evidence about the potential for misoprostol to prevent bleeding after home births in low resource countries.
C Acelity, a global advanced wound care company, today announced the global launch of the V.A.C. VERAFLO CLEANSE CHOICE Dressing, providing clinicians with a novel, adjunctive non-surgical option that may help clean large complex wounds when complete surgical debridement is not possible or appropriate.
› Verified 2 days ago